Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PolyTechnos Venture-Partners is a Munich-based venture capital firm that specialized in early-stage investments in the life sciences and information technology sectors. Established in 1998, the firm played a significant role in the European biotech ecosystem, funding companies involved in drug discovery, medical technology, and diagnostics. Its portfolio has included notable names such as 4SC, Ganymed Pharmaceuticals, and Jerini. The firm primarily targeted high-growth opportunities within German-speaking regions and broader Europe. Currently, PolyTechnos is no longer active in making new investments and focuses on managing its remaining portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PolyTechnos Venture-Partners.